| Members |
targetComponentId |
| Diclofenac sodium 50mg dispersible tablet (product) |
Diclofenac sodium 250 microgram/mL oral solution |
| Dicloxacillin sodium 62.5mg/5mL suspension (product) |
Dicloxacillin 12.5 mg/mL oral suspension |
| Dicobalt edetate allergy |
Allergy to edetate (finding) |
| Didanosine 100mg powder for oral solution (product) |
Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Didanosine 167mg/pkg powder (product) |
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Didanosine 250mg/pkg powder (product) |
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Didanosine 2g/bot powder (product) |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Didanosine 4g/bot powder (product) |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Dideoxyinosine |
Product containing didanosine (medicinal product) |
| Dietary calorie intake |
Energy intake (observable entity) |
| Dietary sodium - average |
Dietary sodium intake normal (finding) |
| Dietary substance |
Edible substance (substance) |
| Dietary treatment and advice (disorder) |
Dietetic procedures |
| Diethylpropion hydrochloride 75mg m/r tablet (product) |
Diethylpropion only product in oral dose form |
| Diethylpropion hydrochloride 75mg prolonged-release oral tablet (product) |
Diethylpropion only product in oral dose form |
| Diethylpropion hydrochloride 75mg tablet (product) |
Diethylpropion only product in oral dose form |
| Difficult intubation (procedure) |
Difficult intubation |
| Diffuse neurodermatitis of Brocq (disorder) |
dermatite atopique |
| Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma |
Precursor cell lymphoblastic lymphoma |
| Diffuse non-Hodgkin's lymphoma, lymphoblastic (clinical) |
Precursor cell lymphoblastic lymphoma |
| Diffuse unilateral subacute neuroretinitis (situation) |
Diffuse unilateral subacute neuroretinitis |
| Difluprednate 0.05% ophthalmic emulsion (product) |
Difluprednate 500 microgram/mL eye suspension |
| Digestive endoscope |
Endoscope |
| Digoxin 38mg/vial injection (product) |
Digoxin immune fab only product |
| Digoxin immune fab 38mg/vial powder for injection 4mL vial (product) |
Digoxin immune fab only product |
| Digoxin specific antibody 38mg powder for injection solution vial (product) |
Digoxin immune fab only product |
| Dihydrocarbostyril derivative antipsychotic agent (substance) |
Dihydrocarbostyril derivative |
| Dihydroergotamine mesylate 1mg/mL injection solution ampule (product) |
Dihydroergotamine mesylate 1 mg/mL solution for injection |
| Dihydroergotamine mesylate 4mg/1mL nasal spray (product) |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
| Dihydroergotamine mesylate allergy |
Allergy to dihydroergotamine |
| Dihydrofolate reductase deficiency (disorder) |
Deficiency of dihydrofolate reductase |
| Dihydroindolone derivative antipsychotic agent (substance) |
Dihydroindolone derivative (substance) |
| Dilation of colon (procedure) |
Dilation of colon |
| Dilation of colostomy stoma |
Dilation of colostomy stoma |
| Diltiazem 180mg m/r tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 180mg prolonged-release oral tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 240mg m/r tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 240mg prolonged-release oral tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 300mg m/r tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 300mg prolonged-release oral tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 360mg m/r tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 360mg prolonged-release oral tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 420mg m/r tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem 420mg prolonged-release oral tablet (product) |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg m/r capsule (product) |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg prolonged-release oral capsule (product) |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 5mg/mL solution (product) |
Product containing only diltiazem in parenteral dose form (medicinal product form) |
| Dimeglumine gadopentetate (product) |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate (product) |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate 469.01mg/mL injection solution prefilled syringe (product) |
Gadopentetic acid only product |
| Dimeglumine gadopentetate 469.01mg/mL injection solution vial (product) |
Gadopentetic acid only product |
| Dingo dog |
Canis lupus dingo |
| Dinoprostone 10mg insert (product) |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Dinoprostone 10mg suppository |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Dioxygenase |
Dioxygenase |
| Dipeptide hydrolase |
Dipeptide hydrolase |
| Dipeptidyl carboxypeptidase II |
Dipeptidyl carboxypeptidase II (substance) |
| Dipeptidylpeptide hydrolase |
Dipeptidylpeptide hydrolase |
| Dipetalonema perstans |
Mansonella perstans |
| Diphenhydramine 2%/zinc acetate 0.1% topical cream (product) |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
| Diphenhydramine hydrochloride 12.5mg/5mL elixir (product) |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 12.5mg/5mL syrup (product) |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup (product) |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup (product) |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenylmethane diisocyanate specific extract (product) |
Diphenylmethane di-isocyanate |
| Diphtheria and tetanus double vaccination NOS |
vaccination contre la diphtérie et le tétanos |
| Diphtheria and tetanus double vaccination NOS |
vaccination contre la diphtérie et le tétanos |
| Diphtheria toxin skin test |
toxine diphtérique |
| Diphtheria, pertussis and tetanus triple vaccination |
vaccination contre la diphtérie, le tétanos et la coqueluche |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
vaccination contre la diphtérie, le tétanos et la coqueluche |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
vaccination contre la diphtérie, le tétanos et la coqueluche |
| Dipivefrin hydrochloride 0.1% eye drops (product) |
Dipivefrin hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1% ophthalmic solution (product) |
Dipivefrin hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1%wv solution (product) |
Dipivefrin hydrochloride 1 mg/mL eye solution |
| Direct invasion of adrenal (T3a) (finding) |
American Joint Committee on Cancer cT3a (qualifier value) |
| Direct laryngoscopy with injection into vocal cord, therapeutic (procedure) |
Direct laryngoscopy with injection into vocal cord (procedure) |
| Direct laryngoscopy, diagnostic, newborn |
Direct laryngoscopy |
| Direct laryngoscopy, diagnostic, with operating microscope |
Direct laryngoscopy with operating microscope (procedure) |
| Disability assessment schedule |
World Health Organization Disability Assessment Schedule 2.0 (assessment scale) |
| Discharge from suture line (disorder) |
Discharge from suture line (finding) |
| Disease due to Fimbriariidae |
Disease caused by Fimbriidae (disorder) |
| Disease due to Thysanosomidae |
Disease caused by Thysanosomatinae (disorder) |
| Disease due to superfamily Syngamoidea |
Disease due to family Syngamidae |
| Disease due to Cestoda |
Cestode infection |
| Disease due to Orthopoxviridae |
Disease due to Orthopoxvirus |
| Disease due to Parapoxviridae |
Disease due to Parapoxvirus |
| Disease due to Reovirus |
Disease due to Orthoreovirus |
| Disease due to Trematoda |
Trematode infection |
| Disease of biliary tract (disorder) |
Disorder of biliary tract |
| Disease of endocrine gland |
pathologie gonadique endocrine (trouble) |
| Disease of supporting structures of teeth |
maladie périodontique |
| Disease of teeth |
Tooth disorder |
| Disease of thymus gland, NEC |
Disorder of thymus gland |
| Disinhibition caused by ingestible alcohol |
Disinhibition caused by ethanol |
| Disodium edetate allergy |
Allergy to edetate (finding) |
| Disodium etidronate adverse reaction |
Adverse reaction to etidronic acid |
| Disodium etidronate allergy |
Allergy to etidronic acid (finding) |
| Disodium etidronate and calcium carbonate allergy |
Allergy to etidronic acid (finding) |
| Disodium pamidronate adverse reaction |
Adverse reaction to pamidronic acid (disorder) |
| Disodium pamidronate allergy |
Allergy to pamidronic acid (finding) |
| Disodium tiludronate (product) |
acide tiludronique |
FHIR